Carregant...

LncRNA MALAT1 promotes development of mantle cell lymphoma by associating with EZH2

BACKGROUND: Mantle cell lymphoma (MCL) is considered an aggressive subtype of non-Hodgkin’s lymphoma with variable treatment responses. There is an urgent need to identify novel markers with prognostic and therapeutic value for MCL. Long non-coding RNAs (lncRNAs) have emerged as key regulators in ca...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Transl Med
Autors principals: Wang, Xin, Sehgal, Lalit, Jain, Neeraj, Khashab, Tamer, Mathur, Rohit, Samaniego, Felipe
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2016
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5175387/
https://ncbi.nlm.nih.gov/pubmed/27998273
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12967-016-1100-9
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!